Role of anidulafungin in solid organ transplant recipients;Papel de la anidulafungina en el paciente con trasplante de órgano sólido

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 26, Issue SUPPL. 14, 2008, Pages 29-34

  Aguado, José M ^a   Ayats, Josefina ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Anidulafungin; Aspergillus; Candida; Fungal infection; Solid organ transplantation

Indexed keywords

ANIDULAFUNGIN; CASPOFUNGIN; CYCLOSPORIN A; ECHINOCANDIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; ANTIFUNGAL AGENT; IMMUNOSUPPRESSIVE AGENT;

ANTIFUNGAL ACTIVITY; ASPERGILLUS; CANDIDA; CRYPTOCOCCUS; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; GRAFT RECIPIENT; HIGH RISK PATIENT; HUMAN; IN VITRO STUDY; KIDNEY FUNCTION; LIVER DISEASE; LIVER METABOLISM; MORTALITY; MYCOSIS; ORGAN TRANSPLANTATION; REVIEW; RISK FACTOR; SYSTEMIC MYCOSIS; ASPERGILLOSIS; CANDIDIASIS; CRYPTOCOCCOSIS; DRUG INTERACTION; FUNGEMIA; IMMUNE DEFICIENCY; KIDNEY; LIVER; METABOLISM; POSTOPERATIVE COMPLICATION; PREMEDICATION;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; CANDIDIASIS; CRYPTOCOCCOSIS; DRUG INTERACTIONS; ECHINOCANDINS; FUNGEMIA; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LIVER; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; RISK FACTORS;

EID: 69249209976     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(08)76590-X     Document Type: Article

References (41)

1. J. Briegel, H. Forst, B. Spill, A. Haas, B. Grabein, M. Haller, et al. Risk factors for systemic fungal infections in liver transplant recipients Eur J Clin Microbiol Infect Dis 14 1995 375 382
2. N. Singh, T. Gayowski, M.M. Wagener, H. Doyle, and I.R. Marino Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent Clin Infect Dis 24 1997 179 184 (Pubitemid 27081540)
3. J. Gavalda, O. Len, R. San Juan, J.M. Aguado, J. Fortún, and C. Lumbreras Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study Clin Infect Dis 41 2005 52 59 (Pubitemid 40863744)
4. D.L. Paterson, and N. Singh Invasive aspergillosis in transplant recipients Medicine 78 1999 123 138 (Pubitemid 29153028)
5. S. Kusne, J. Torre Cisneros, R. Mañez, W. Irish, M. Martin, J. Fung, et al. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation J Infect Dis 166 1992 1379 1383
6. N. Singh, P.M. Arnow, A. Bonham, E. Dominguez, D.L. Paterson, and G.A. Pankey Invasive aspergillosis in liver transplant recipients in the 1990 Transplantation 64 1997 716 720 (Pubitemid 27407098)
7. S. Kusne, D. Tobin, A.W. Pasculle, D.H. Van Thiel, M. Ho, and T.E. Starzl Candida carriage in the alimentary tract of liver transplant candidates Transplantation 57 1994 398 402 (Pubitemid 24086038)
8. C.V. Paya Fungal infections in solid-organ transplantation Clin Infect Dis 16 1993 677 688
9. N. Singh Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy Clin Infect Dis 31 2000 545 553 (Pubitemid 32289589)
10. J. Fortún, P. Martín-Dávila, S. Moreno, E. De Vicente, J. Nuño, and J. Candelas Risk factors for invasive Aspergillosis in liver transplant recipients Liver Transplant 8 2002 1065 1070 (Pubitemid 35363635)
11. J. Canales, C.D. Gove, A.E. Gimson, S.P. Wilkinson, E.N. Wardle, and R. Williams Reticuloendothelial system and hepatocyte function in fulminant hepatic failure Gut 23 1982 265
12. M. Imawari, R.D. Hughes, C.D. Gove, and R. Williams Fibronectin and Kupffer cell function in fulminant hepatic failure Dig Dis Sci 30 1985 1028
13. R. Patel, D. Portela, A.D. Badley, W.S. Harmsen, J.H. Larson-Keller, and D.M. Ilstrup Risk factors of invasive candida and non-candida fungal infections after liver transplantation Transplantation 62 1996 926 934 (Pubitemid 26360353)
14. L.A. Collins, M.H. Samore, M.S. Roberts, R. Luzzati, R.L. Jenkins, and W.D. Lewis Risk factors for invasive fungal infections complicating orthotopic liver transplantation J Infect Dis 170 1994 644 652 (Pubitemid 24262267)
15. F.P. Silveira, and S. Husain Fungal Infections in solid organ transplantation Med Mycol 45 2007 305 320 (Pubitemid 46839801)
16. S. Husain, B.D. Alexander, P. Munoz, R.K. Avery, S. Houston, and T. Pruett Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi Clin Infect Dis 37 2003 221 229 (Pubitemid 36930353)
17. M. Nucci Emerging moulds: Fusarium, Scedosporium and zygomycetes in transplant recipients Curr Opin infec Dis 16 2003 607 612
18. W.J. Steinbach, W.A. Schell, J.R. Blankenship, C. Onyewu, J. Heitman, and J.R. Perfect In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus Antimicrob Agents Chemother 48 2004 1664 1669 (Pubitemid 38544372)
19. F.M. Marty, C.M. Lowry, C.S. Cutler, B.J. Campbell, K. Fiumara, and L.R. Baden Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation Biol Blood Marrow Transplant 12 2006 552 559 (Pubitemid 43956360)
20. N. Singh, A.P. Limaye, G. Forrest, N. Safdar, P. Muñoz, and K. Pursall Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study Transplantation 81 2006 320 326 (Pubitemid 43255714)
21. J.A. Martínez Martínez, J. Mensa Pueyo, and F. Marco Características generales y farmacocinética de caspogungina Drugs Today 38 Supl 3 2002 15 24
22. C. Wagner, W. Graninger, E. Presterl, and C. Joukhadar The echinocandins: Comparison of their pharmacokinetics, pharmacodynamics and clinical applications Pharmacology 78 2006 161 177 (Pubitemid 44948055)
23. J.A. Dowell, M. Stogniew, D. Krause, T. Henkel, and B. Damle Lack of pharmacokinetic interaction between anidulafungin and tacrolimus J Clin Pharmacol 47 2007 305 314 (Pubitemid 46294710)
24. J.A. Dowell, W. Knebel, T. Ludden, M. Stogniew, D. Krause, and T. Henkel Population pharmacokinetic analysis of anidulafungin, an echinocandin antifungal J Clin Pharmacol 44 2004 590 598 (Pubitemid 38668021)
25. J.A. Dowell, M. Stogniew, D. Krause, T. Henkel, and I.E. Weston Assessment of the safety and pharmacokinetics of anidulafungin when administered with cyclosporine J Clin Pharmacol 45 2005 227 233 (Pubitemid 40490447)
26. A. Philip, Z. Odabasi, J. Rodriguez, V.L. Paetznick, E. Chen, and J.H. Rex In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp Antimicrob Agents Chemother 49 2005 3572 3574 (Pubitemid 41060623)
27. J.A. Dowell, J. Schranz, A. Baruch, and G. Foster Safety and pharmacokinetics of coadministered voriconazole and anidulafungin J Clin Pharmacol 45 2005 1373 1382 (Pubitemid 41642440)
28. A.C. Reboli, C. Rotstein, P.G. Pappas, S.W. Chapman, D.M. Kett, and D. Kumar Anidulafungin versus fluconazole for invasive candidiasis N Engl J Med 356 2007 2472 2482 (Pubitemid 46919773)
29. B.D. Brielmaier, E. Casabar, C.M. Kurtzeborn, P.S. McKinnon, and D.J. Ritchie Early clinical experience with anidulafungin at a large tertiary care medical center Pharmacotherapy 28 2008 64 73
30. D.J. Winston, A. Pakrasi, and R.W. Busuttil Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial Ann Intern Med 131 1999 729 737 (Pubitemid 29531981)
31. V. Monforte, A. Roman, J. Gavalda, C. Bravo, L. Tenorio, and A. Ferrer Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors J Heart Lung Transplant 20 2001 1274 1281 (Pubitemid 34017312)
32. J. Gavaldà, T. Martín, and P. López Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis Clin Microbiol Infect 11 2005 999 1004 (Pubitemid 41748934)
33. W.D. Colby, M.D. Sharpe, C.N. Ghent, D.R. Grant, L. Hunte, J. McDougall, et al. Efficacy of itraconazole prophylaxis against systemic fungal infection in liver transplant recipients 39th Interscience Conference on Antimicrobial Agents and Chemotherapy San Franciscop 1999
34. N. Singh, L. Mieles, V.L. Yu, and T. Gayowski Invasive aspergillosis in liver transplant recipients: association with candidemia and consumption coagulopathy and failure of prophylaxis with low-dose amphotericin B Clin Infect Dis 17 1993 906 908 (Pubitemid 23321917)
35. J. Tollemar, K. Hockerstedt, B.G. Ericzon, H. Jalanko, and O. Ringden Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study Transplantation 59 1995 45 50
36. N. Singh, D.L. Paterson, T. Gayowski, and M.M. Wagener Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requering renal replacement therapy Transplantation 71 2001 910 913 (Pubitemid 32417353)
37. J. Fortún, P. Martin-Davila, M. Uriarte, A. Candela, R. Bárcena, E. De Vicente, et al. Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients 42nd ICAAC Abstracts. American Society for Microbiology September 27-30, San Diego 2002 315
38. T. Lorf, F. Braun, R. Ruchel, A. Muller, B. Sattler, and B. Ringe Systemic mycoses during prophylactical use of liposomal amphotericin B (Ambisome) after liver transplantation Mycoses 42 1999 47 53 (Pubitemid 29256326)
39. E. Varo, S. Tome, M. Bustamante, et al. Fungal infection prophylaxis in high-risk liver transplant recipients 38th ICAAC Abstracts, American Society for Microbiology San Diego 1998
40. R. Petraitiene, V. Petraitis, A.H. Groll, T. Sein, R.L. Schaufele, and A. Francesconi Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia Antimicrob Agents Chemother 46 2002 12 23 (Pubitemid 34031596)
41. J. Fortún, P. Muñoz, P. Martín-Dávila, et al. GESITRA Prospective, Multicenter Study of Caspofungin for Prophylaxis in High Risk Liver Transplantation 46th Interscience Conference on Antimicrobial Agents and Chemotherapy San Franciso, September 27-30 2006